NASDAQ:MMED
MiniMed Group, Inc.
MiniMed Group, Inc.'s revenue grew 14.3% in fiscal 2026 to $3.1B while operating margin fell to −6.1%, its lowest in 3 years. Free cash flow was −$420.0M, −13.5% of revenue, and the diluted share count rose 1.5%.Summary generated from MiniMed Group, Inc.'s SEC filings. Latest annual report filed Jun 29, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$3.1B
Revenue growth+14.3%
Revenue, 5-yr CAGRn/a
Gross margin54.2%
Operating margin−6.1%
Net margin−10.7%
ROICn/a
Return on equity−9.6%
Debt / equityn/a
Free cash flow−$420.0M
FCF margin−13.5%
Share count change+1.5%
Financials
| Item | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 2,469 | 2,715 | 3,102 |
| Operating income | −69 | −146 | −190 |
| Net income | −112 | −213 | −333 |
| Free cash flow | −107 | −53 | −420 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 10-QQuarterly report for the period ended Jul 31, 2026
Sep 8, 2026 - 8-KResults of operations and financial condition
Sep 1, 2026 - DEF 14AProxy statement
Aug 21, 2026 - 8-KDirector or officer change
Aug 5, 2026 - 4Insider transaction report
Aug 4, 2026 - 10-KAnnual report for the fiscal year ended Apr 24, 2026
Jun 29, 2026 - 8-KDirector or officer change
Jun 29, 2026